1. Home
  2. ICAD vs AXTI Comparison

ICAD vs AXTI Comparison

Compare ICAD & AXTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ICAD
  • AXTI
  • Stock Information
  • Founded
  • ICAD 1984
  • AXTI 1986
  • Country
  • ICAD United States
  • AXTI United States
  • Employees
  • ICAD N/A
  • AXTI N/A
  • Industry
  • ICAD Medical/Dental Instruments
  • AXTI Semiconductors
  • Sector
  • ICAD Health Care
  • AXTI Technology
  • Exchange
  • ICAD Nasdaq
  • AXTI Nasdaq
  • Market Cap
  • ICAD 87.5M
  • AXTI N/A
  • IPO Year
  • ICAD 1986
  • AXTI 1998
  • Fundamental
  • Price
  • ICAD $3.31
  • AXTI $1.38
  • Analyst Decision
  • ICAD Hold
  • AXTI Strong Buy
  • Analyst Count
  • ICAD 1
  • AXTI 4
  • Target Price
  • ICAD N/A
  • AXTI $5.50
  • AVG Volume (30 Days)
  • ICAD 1.6M
  • AXTI 414.1K
  • Earning Date
  • ICAD 05-14-2025
  • AXTI 05-01-2025
  • Dividend Yield
  • ICAD N/A
  • AXTI N/A
  • EPS Growth
  • ICAD N/A
  • AXTI N/A
  • EPS
  • ICAD N/A
  • AXTI N/A
  • Revenue
  • ICAD $19,608,000.00
  • AXTI $99,361,000.00
  • Revenue This Year
  • ICAD $2.58
  • AXTI $7.51
  • Revenue Next Year
  • ICAD $14.78
  • AXTI $18.42
  • P/E Ratio
  • ICAD N/A
  • AXTI N/A
  • Revenue Growth
  • ICAD 13.22
  • AXTI 31.09
  • 52 Week Low
  • ICAD $1.18
  • AXTI $1.13
  • 52 Week High
  • ICAD $3.78
  • AXTI $4.23
  • Technical
  • Relative Strength Index (RSI)
  • ICAD 70.59
  • AXTI 46.49
  • Support Level
  • ICAD $3.00
  • AXTI $1.14
  • Resistance Level
  • ICAD $3.34
  • AXTI $1.39
  • Average True Range (ATR)
  • ICAD 0.17
  • AXTI 0.12
  • MACD
  • ICAD 0.17
  • AXTI 0.02
  • Stochastic Oscillator
  • ICAD 89.62
  • AXTI 60.00

About ICAD iCAD Inc.

icad Inc is a medical technology company providing cancer detection and therapy solutions. The Company operates in one segment: Detection. The Detection segment include advanced image analysis and workflow solutions that enable healthcare professionals to serve patients by identifying pathologies, comprehensive range of high-performance, Artificial Intelligence and Computer-Aided Detection (CAD) systems and workflow solutions for 2D and 3D mammography, Magnetic Resonance Imaging and Computed Tomography. The company geographically operates in France, Belgium, Italy, Germany, Switzerland and All other.

Share on Social Networks: